Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus

Journal of Rheumatology

Volumn 36, Issue 4, 2009, Pages 753-756

  Rosenau, Barbara J ^a   Schur, Peter H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anti tumor necrosis factor antibodies; Rheumatoid arthritis; Systemic lupus erythematosus; Tumor necrosis factor

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL LABORATORY; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; INFLAMMATION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; FEMALE; IMMUNOLOGY; MIDDLE AGED;

ADULT; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66149137210     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080587     Document Type: Article

References (18)

1. Erkkila AT, Narvanen O, Lehto S, Matti IJ, Usitupa SY. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2000;20:204-9.
2. Roubey RAS, Eisenberg RA, Harper MF, Winfield JB. Anti-cardiolipin antibodies recognize β2-glycoprotein 1 in the absence of phospholipid. J Immunol 1995;154:954-60.
3. Galli M. Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome? J Autoimmun 2000;15:101-5.
4. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: detection by radio immunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;2:1211-4.
5. Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep red blood corpuscles. Acta Pathol Microbiol Scand 1940;17:172-8.
6. Fong S, Gilbertson TA, Carson DA. The internal image of IgG factors. J Immunol 1983;131:719-24.
7. Bell SA, Du Close TW, Khursigara G, et al. Auto antibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in the toxic oil syndrome. J Autoimmunity 1995;8:293-303.
8. Rosenau BJ, Schur PH. Antibody to serum amyloid A. J Autoimmun 2004;23:179-82.
9. Sjowall C, Eriksson P, Almer S, Skogh T. Auto antibodies to C-reactive protein is a common finding in SLE, but not in primary Sjogren's syndrome, rheumatoid arthritis or inflammatory bowel disease. J Autoimmunity 2002;19:155-60.
10. Bell SA, Faust H, Schmid A, Meurer M. Auto antibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune disease. Clin Exp Immunol 1998;113:327-32.
11. Rosenau BJ, Schur PH. Antibodies to C reactive protein. Ann Rheum Dis 2006;65:674-6.
12. Lindqvist E, Eberhardt K, Bendtzen K, et al. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005;64:196.
13. Elkon K. Autoantibodies in systemic lupus erythematosus. Curr Opinion Rheumatol 1995;7:384.
14. Sjowall C, Ernerudh J, Bengtsson AA, et al. Reduced anti-TNFa autoantibody levels coincide with flare in systemic lupus erythematosus. J Autoimmunity 2004;22:315-23.
15. Whicker JT, Ritchie RF, Johnson AM, et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994;40:934-8.
16. Bedell SE, Bush BT. Erythrocyte sedimentation rate. From folklore to facts. Am J Med 1985;78:1001-9.
17. Weinblatt ME, Schur PH. Rheumatoid factor detection by nephelometry. Arthritis Rheum 1980;23:777-9.
18. Lee DN, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003;62:870-4.